(Q37928842)

25 August 2017

1 reference

title

Endogenous uveitis: current concepts of treatment (English)

1 reference

25 August 2017

1 reference

D C Herman

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 May 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

65

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

671-683

1 reference

Pre-keratoplasty potential acuity evaluation. Laser interferometer and potential acuity meter

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Potential acuity meter for predicting visual acuity after Nd:YAG posterior capsulotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Laser interferometry and visual prognosis in uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Immunosuppressive therapy for external ocular inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Immunosuppressive Therapy for Severe Chronic Uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Cyclophosphamide Therapy of Peripheral Uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Treatment of Behçet's disease with chlorambucil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

The Treatment of Uveitis with Six-Mercaptopurine*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Cytotoxic drugs: their clinical application to the rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Cytotoxic drug-induced pulmonary disease: update 1980.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

The influence of pituitary hormones on adjuvant arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

The effect of bromocriptine on anterior uveitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

Treatment and visual prognosis in Behçet's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965130-1

10.1016/S0025-6196(12)65130-1

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference